Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyan Lu

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.
Blood Advances|June 23, 2023
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignanciesSophie A Herbst, Vladislav Kim, Tobias Roider, et al.
Blood Advances|August 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progressionPau Abrisqueta, Daniel Medina, Guillermo Villacampa, et al.
Nature Neuroscience|May 27, 2014
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memoryNitai C Hait, Laura E Wise, Jeremy C Allegood, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2016
Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assaysYunlong Wu, Junchi Hu, Hong Ding, et al.
American Journal of Nephrology|November 7, 2019
A Sphingosine-1-Phosphate Modulator Ameliorates Polycystic Kidney Disease in Han:SPRD RatsXin Li, Ming Wu, Limin Chen, et al.
BMC Nephrology|February 11, 2022
Nomogram to predict rapid kidney function decline in population at risk of cardiovascular diseaseQiuxia Zhang, Junyan Lu, Li Lei, et al.
Journal of Medicinal Chemistry|November 5, 2014
Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2Xiangqian Kong, Limin Chen, Lianying Jiao, et al.
BMJ Open|November 13, 2021
Nomogram to predict risk of incident chronic kidney disease in high-risk population of cardiovascular disease in China: community-based cohort studyQiuxia Zhang, Jingyi Zhang, Li Lei, et al.
Organic & Biomolecular Chemistry|August 10, 2012
Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimizationXiangqian Kong, Jie Qin, Zeng Li, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.
Blood Advances|June 23, 2023
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignanciesSophie A Herbst, Vladislav Kim, Tobias Roider, et al.
Blood Advances|August 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progressionPau Abrisqueta, Daniel Medina, Guillermo Villacampa, et al.
Nature Neuroscience|May 27, 2014
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memoryNitai C Hait, Laura E Wise, Jeremy C Allegood, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2016
Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assaysYunlong Wu, Junchi Hu, Hong Ding, et al.
American Journal of Nephrology|November 7, 2019
A Sphingosine-1-Phosphate Modulator Ameliorates Polycystic Kidney Disease in Han:SPRD RatsXin Li, Ming Wu, Limin Chen, et al.
BMC Nephrology|February 11, 2022
Nomogram to predict rapid kidney function decline in population at risk of cardiovascular diseaseQiuxia Zhang, Junyan Lu, Li Lei, et al.
Journal of Medicinal Chemistry|November 5, 2014
Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2Xiangqian Kong, Limin Chen, Lianying Jiao, et al.
BMJ Open|November 13, 2021
Nomogram to predict risk of incident chronic kidney disease in high-risk population of cardiovascular disease in China: community-based cohort studyQiuxia Zhang, Jingyi Zhang, Li Lei, et al.
Organic & Biomolecular Chemistry|August 10, 2012
Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimizationXiangqian Kong, Jie Qin, Zeng Li, et al.
Pageof 10